129 related articles for article (PubMed ID: 24211075)
1. A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells.
Misra SK; Naz S; Kondaiah P; Bhattacharya S
Biomaterials; 2014 Jan; 35(4):1334-46. PubMed ID: 24211075
[TBL] [Abstract][Full Text] [Related]
2. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
3. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group.
Biswas J; Mishra SK; Kondaiah P; Bhattacharya S
Org Biomol Chem; 2011 Jun; 9(12):4600-13. PubMed ID: 21537498
[TBL] [Abstract][Full Text] [Related]
5. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes.
Ndoye A; Merlin JL; Leroux A; Dolivet G; Erbacher P; Behr JP; Berg K; Guillemin F
J Gene Med; 2004 Aug; 6(8):884-94. PubMed ID: 15293347
[TBL] [Abstract][Full Text] [Related]
6. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
Rejeeth C; Salem A
J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
[TBL] [Abstract][Full Text] [Related]
7. An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo.
Li YY; Wang R; Zhang GL; Zheng YJ; Zhu P; Zhang ZM; Fang XX; Feng Y
Cancer Gene Ther; 2007 Dec; 14(12):968-75. PubMed ID: 17853924
[TBL] [Abstract][Full Text] [Related]
8. Calcium carbonate microparticles used as a gene vector for delivering p53 gene into cancer cells.
Kong X; Xu S; Wang X; Cui F; Yao J
J Biomed Mater Res A; 2012 Sep; 100(9):2312-8. PubMed ID: 22529011
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
10. α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.
Kumar K; Maiti B; Kondaiah P; Bhattacharya S
Org Biomol Chem; 2015 Feb; 13(8):2444-52. PubMed ID: 25563750
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
12. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ
Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335
[TBL] [Abstract][Full Text] [Related]
13. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.
Seki M; Iwakawa J; Cheng H; Cheng PW
Hum Gene Ther; 2002 Apr; 13(6):761-73. PubMed ID: 11936974
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
15. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
17. Structure-transfection activity studies of novel cationic cholesterol-based amphiphiles.
Kearns MD; Donkor AM; Savva M
Mol Pharm; 2008; 5(1):128-39. PubMed ID: 18159927
[TBL] [Abstract][Full Text] [Related]
18. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
19. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
20. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
